Evidence map›Paper›PMID 25277726›Full record

ArticleThe International journal on drug policy2015

Women, drugs and HIV.

Tasnim Azim, Irene Bontell, Steffanie A Strathdee

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The International journal on drug policy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06789523 (Friendship Bench for Women Who Use Methamphetamine in Vietnam), which is not on this map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06789523 narecruitingnot on this mapstarted 2025, after this paper: background citation

Friendship Bench for Women Who Use Methamphetamine in Vietnam

TypeinterventionalSponsorHanoi Medical UniversityRan2025 to 2029Enrolled100ConditionsMethamphetamine Use, Common Mental Disorders (CMD)ArmsFriendship Bench, Usual psychiatric care
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Women's Decision-Making about PrEP for HIV Prevention in Drug Treatment Contexts.Journal of the International Association of Providers of AIDS Care
    Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Tasnim AzimCentre for HIV and AIDS, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh. Electronic address: tasnim@icddrb.org.
Irene BontellCentre for HIV and AIDS, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh; Unit of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden.
Steffanie A StrathdeeDivision of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
International Centre for Diarrhoeal Disease Research · BDKarolinska Institutet · SEUniversity of California, San Diego · US

Funding

Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in TijuanaR37DA019829 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2010 to 2019
$6.7M
NIDA NIH HHS R37 DA019829
6 · The paper itself

Abstract

backgroundWomen who use drugs, irrespective of whether these are injected or not, are faced with multiple issues which enhance their vulnerability to HIV.

methodsIn this commentary, we explore the HIV risks and vulnerabilities of women who use drugs as well as the interventions that have been shown to reduce their susceptibility to HIV infection.

resultsWomen who inject drugs are among the most vulnerable to HIV through both unsafe injections and unprotected sex. They are also among the most hidden affected populations, as they are more stigmatized than their male counterparts. Many sell sex to finance their own and their partner's drug habit and often their partner exerts a significant amount of control over their sex work, condom use and injection practices. Women who use drugs all over the world face many different barriers to HIV service access including police harassment, judgmental health personnel and a fear of losing their children.

conclusionIn order to enable these women to access life-saving services including needle-syringe and condom programs, opioid substitution therapy and HIV testing and treatment, it is essential to create a conducive environment and provide tailor-made services that are adapted to their specific needs.

Indexed as

FemaleHarm ReductionHealth Services AccessibilityHIV InfectionsHumansMaleRisk FactorsSex FactorsSocial StigmaSubstance Abuse, IntravenousSubstance-Related DisordersUnsafe SexDrug useFemalesHarm reductionHIVPeople who inject drugsSex work

Identifiers

PMID25277726
PMCPMC4498573
OpenAlexW2158620025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.